{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T07:36:14Z","timestamp":1791012974865,"version":"4.1.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.jtct.2022.05.015","type":"journal-article","created":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T15:41:33Z","timestamp":1652542893000},"page":"401.e1-401.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["Change in Patients\u2019 Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma"],"prefix":"10.1016","volume":"28","author":[{"given":"Anna","family":"Barata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8691-8132","authenticated-orcid":false,"given":"Aasha I.","family":"Hoogland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuhya","family":"Kommalapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"Welniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Hyland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L.","family":"Eisel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7444-4689","authenticated-orcid":false,"given":"Brent J.","family":"Small","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5291-5945","authenticated-orcid":false,"given":"Reena V.","family":"Jayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Booth-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6281-2512","authenticated-orcid":false,"given":"Laura B.","family":"Oswald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian D.","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1302-9577","authenticated-orcid":false,"given":"Kedar S.","family":"Kirtane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sepideh","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio C.","family":"Chavez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandr","family":"Lazaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijal D.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick L.","family":"Locke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7353-3711","authenticated-orcid":false,"given":"Heather S.L.","family":"Jim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.05.015_bib0001","doi-asserted-by":"crossref","first-page":"3312","DOI":"10.1182\/blood-2016-02-629063","article-title":"CD19-targeted CAR T-cell therapeutics for hematologic malignancies: interpreting clinical outcomes to date","volume":"127","author":"Park","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.015_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0003","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1056\/NEJMoa1707447","article-title":"Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma","volume":"377","author":"Neelapu","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.05.015_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.05.015_bib0005","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1182\/blood-2016-04-703751","article-title":"Toxicities of chimeric antigen receptor T cells: recognition and management","volume":"127","author":"Brudno","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.015_bib0006","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1056\/NEJMoa1804980","article-title":"Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma","volume":"380","author":"Schuster","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.05.015_bib0007","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.bbmt.2018.12.758","article-title":"ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells","volume":"25","author":"Lee","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nrclinonc.2017.148","article-title":"Chimeric antigen receptor T-cell therapy\u2014assessment and management of toxicities","volume":"15","author":"Neelapu","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0009","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bbmt.2019.09.037","article-title":"Patient-reported neuropsychiatric outcomes of long-term survivors after chimeric antigen receptor t cell therapy","volume":"26","author":"Ruark","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0010","doi-asserted-by":"crossref","first-page":"e155","DOI":"10.1016\/j.bbmt.2018.11.025","article-title":"Patient-reported outcomes with chimeric antigen receptor t cell therapy: challenges and opportunities","volume":"25","author":"Chakraborty","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0011","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/jnci\/djz168","article-title":"Potential effect of immunotherapy agents on cognitive function in cancer patients","volume":"112","author":"Joly","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2022.05.015_bib0012","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1001\/jamaoncol.2016.2047","article-title":"Subjective or objective measures of cognitive functioning\u2014what's more important?","volume":"2","author":"Savard","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0013","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1002\/cam4.2069","article-title":"Cognitive complaints in cancer survivors and expectations for support: results from a web-based survey","volume":"8","author":"Lange","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.jtct.2022.05.015_bib0014","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","article-title":"Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors","volume":"30","author":"Lange","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0015","first-page":"12","article-title":"Perceived cognitive impairment in breast cancer survivors and its relationships with psychological factors","author":"Boscher","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jtct.2022.05.015_bib0016","article-title":"Longitudinal changes in cognitive function in a nationwide cohort study of patients with lymphoma treated with chemotherapy","author":"Janelsins","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jtct.2022.05.015_bib0017","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.78.6624","article-title":"Longitudinal trajectory and characterization of cancer-related cognitive impairment in a nationwide cohort study","author":"Janelsins","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0018","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.18.00140","article-title":"Cancer-related cognitive outcomes among older breast cancer survivors in the Thinking and Living With Cancer study","author":"Mandelblatt","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0019","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1080\/10428194.2020.1728748","article-title":"Cognitive function in patients with chronic lymphocytic leukemia: a cross-sectional study examining effects of disease and treatment","volume":"61","author":"Williams","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.05.015_bib0020","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/cncr.33397","article-title":"Systemic inflammation and symptomatology in patients with prostate cancer treated with androgen deprivation therapy: preliminary findings","volume":"127","author":"Hoogland","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.05.015_bib0021","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2019.04.008","article-title":"Worsening cognitive performance is associated with increases in systemic inflammation following hematopoietic cell transplantation","volume":"80","author":"Hoogland","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"Suppl","key":"10.1016\/j.jtct.2022.05.015_bib0022","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.bbi.2012.07.015","article-title":"Does tumor necrosis factor-alpha (TNF-\u03b1) play a role in post-chemotherapy cerebral dysfunction?","volume":"30","author":"Ganz","year":"2013","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.jtct.2022.05.015_bib0023","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1093\/annonc\/mdv206","article-title":"Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study","volume":"26","author":"Cheung","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jneuroim.2017.10.005","article-title":"Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy","volume":"314","author":"Williams","year":"2018","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0025","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.bbmt.2010.01.003","article-title":"Impact of delirium on distress, health-related quality of life, and cognition 6 months and 1 year after hematopoietic cell transplant","volume":"16","author":"Basinski","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0026","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1200\/JCO.2006.07.9079","article-title":"Impact of delirium on cognition, distress, and health-related quality of life after hematopoietic stem-cell transplantation","volume":"25","author":"Fann","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0027","article-title":"Relationship between cognitive functioning and frailty in older breast cancer survivors","author":"Ahles","year":"2021","journal-title":"J Geriatr Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0028","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jpainsymman.2018.11.015","article-title":"Pretreatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors","volume":"57","author":"Tometich","year":"2019","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jtct.2022.05.015_bib0029","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1017\/S1478951518000664","article-title":"A mixed methods analysis of perceived cognitive impairment in hematopoietic stem cell transplant survivors","volume":"17","author":"Wu","year":"2019","journal-title":"Palliat Support Care"},{"key":"10.1016\/j.jtct.2022.05.015_bib0030","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1002\/pon.2012","article-title":"Self-efficacy beliefs mediate the relationship between subjective cognitive functioning and physical and mental well-being after hematopoietic stem cell transplant","volume":"21","author":"Wu","year":"2012","journal-title":"Psychooncology"},{"key":"10.1016\/j.jtct.2022.05.015_bib0031","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.bmt.1705108","article-title":"Characteristics and correlates of cognitive functioning following bone marrow transplantation","volume":"36","author":"Booth-Jones","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0032","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1182\/blood-2004-03-1155","article-title":"Neuropsychologic changes from before transplantation to 1 year in patients receiving myeloablative allogeneic hematopoietic cell transplant","volume":"104","author":"Syrjala","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.015_bib0033","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bbmt.2017.08.006","article-title":"The role of age in neurocognitive functioning among adult allogeneic hematopoietic cell transplant recipients","volume":"23","author":"Hoogland","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0034","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.05.015_bib0035","series-title":"Revised Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographically Adjusted Neuropsychological Norms for African American and Caucasian Adults","author":"Heaton","year":"2004"},{"key":"10.1016\/j.jtct.2022.05.015_bib0036","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1037\/0894-4105.22.4.531","article-title":"The measurement of everyday cognition (ECog): scale development and psychometric properties","volume":"22","author":"Farias","year":"2008","journal-title":"Neuropsychology"},{"key":"10.1016\/j.jtct.2022.05.015_bib0037","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.jtct.2022.05.015_bib0038","series-title":"SF-36 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"10.1016\/j.jtct.2022.05.015_bib0039","unstructured":"Jensen TS, Chin J, Ashby LM, Canos DA, Paserchia LA, KB S. Proposed national coverage determination for chimeric antigen receptor (CAR) T-cell therapy. CMS.gov2019."},{"key":"10.1016\/j.jtct.2022.05.015_bib0040","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","article-title":"PROMIS-29 v2.0 profile physical and mental health summary scores","volume":"27","author":"Hays","year":"2018","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jtct.2022.05.015_bib0041","series-title":"PROsetta Stone Methodology: A Rosetta Stone for patient reported outcomes","author":"Choi","year":"2021"},{"key":"10.1016\/j.jtct.2022.05.015_bib0042","unstructured":"Littell R, Miliken GA, Stroup WW, Wolfinger RD, Schabenberger O.SAS for Mixed Models. 2nd Edition ed. Cary, NC: 2006."},{"key":"10.1016\/j.jtct.2022.05.015_bib0043","series-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1998"},{"key":"10.1016\/j.jtct.2022.05.015_bib0044","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1200\/JCO.2016.68.5826","article-title":"Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study","volume":"35","author":"Janelsins","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.05.015_bib0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/cncr.10627","article-title":"Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation","volume":"95","author":"Harder","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.05.015_bib0046","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpainsymman.2013.02.014","article-title":"The effects of cognitive behavioral therapy for postcancer fatigue on perceived cognitive disabilities and neuropsychological test performance","volume":"47","author":"Goedendorp","year":"2014","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.jtct.2022.05.015_bib0047","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1177\/1534735415617021","article-title":"YOCAS yoga reduces self-reported memory difficulty in cancer survivors in a nationwide randomized clinical trial: investigating relationships between memory and sleep","volume":"15","author":"Janelsins","year":"2016","journal-title":"Integr Cancer Ther"},{"key":"10.1016\/j.jtct.2022.05.015_bib0048","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/cncr.30987","article-title":"Randomized controlled trial of increasing physical activity on objectively measured and self-reported cognitive functioning among breast cancer survivors: the Memory & Motion Study","volume":"124","author":"Hartman","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2022.05.015_bib0049","doi-asserted-by":"crossref","unstructured":"Hoogland AI, Barata A, Logue J, et\u00a0al. Change in neurocognitive performance among patients with non-Hodgkin lymphoma in the first year after CAR T-cell therapy [e-pub ahead of print April 1, 2022]. Transplant Cell Ther. https:\/\/doi.org\/10.1016\/j.jtct.2022.03.023.","DOI":"10.1016\/j.jtct.2022.03.023"},{"key":"10.1016\/j.jtct.2022.05.015_bib0050","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.bbmt.2016.08.012","article-title":"Trajectories of quality of life after hematopoietic cell transplantation: secondary analysis of Blood and Marrow Transplant Clinical Trials Network 0902 Data","volume":"22","author":"Jim","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.05.015_bib0051","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1182\/blood-2018-12-893396","article-title":"Clinical presentation, management, and biomarkers of neurotoxicity after adoptive immunotherapy with CAR T cells","volume":"133","author":"Karschnia","year":"2019","journal-title":"Blood"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722013070?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722013070?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T23:48:08Z","timestamp":1726444088000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722013070"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":51,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2666636722013070"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.05.015","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Change in Patients\u2019 Perceived Cognition Following Chimeric Antigen Receptor T-Cell Therapy for Lymphoma","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}